Beyond Achondroplasia

Growing together with Clara

April 21, 2016
by inesp.alves

Vosoritide for Achondroplasia – Rare disease day 20th April 2016

On the 20th April at 8am, NY time, Sarah Noonberg, MD, PhD, Group Vice President, Head of Global Clinical Development, presented the updates for Vosoritide. List of presented updates: 10 children, aged 6 to 11, received for 12-month a dose of 15 μg/kg/day (cohort … Continue reading

Translate »